58-60-6CN(C)c1ncnc2c1ncn2C1OC(CO)C(N)C1ORYSMHWILUNYBFW-UHFFFAOYSA-N58-60-6CHEMBL4098422Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionPuromycin aminonucleoside (58-60-6) is the nucleoside moiety of puromycin (Cat.# 10-2100) which does not inhibit protein synthesis or induce apoptosis.1It acts as a glomerular epithelial cell toxin2 and as such is a useful tool for producing animal models of nephropathy3,4, or puromycin aminonucleoside nephrosis (1-2.5 mg/100g rat body weight)5. Active in vivo.
UsesPuromycin aminonucleoside is a semi-synthetic derivative of puromycin which lacks the methoxyphenylalanyl moiety. Puromycin aminonucleoside is the key intermediate in the synthesis of semi-synthetic analogues of puromycin. It does not inhibit protein synthesis or induce apoptosis, but exhibits antitumour properties. Puromycin aminonucleoside-induced nephrosis is a well-described model of human idiopathic nephrotic syndrome, suppressing integrin expression in cultured glomerular epithelial cells.
UsesPuromycin Aminonucleoside is an aminonucleoside portion of the antibiotic puromycin.
DefinitionChEBI: Puromycin derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring.
No reaction records under the current filter.
Loading…